APP下载

甲茅软肝汤加减联合西药治疗肝硬化腹水的效果观察

2014-10-23叶新洲

中国当代医药 2014年27期

叶新洲

[摘要] 目的 探讨甲茅软肝汤加减联合西药治疗肝硬化腹水的临床效果。 方法 将186例肝硬化腹水患者随机分为治疗组94例,对照组92例。对照组采用护肝药物、抗病毒、抗感染、定期输注白蛋白、支持、利尿、腹腔排液等常规治疗;治疗组在对照组的基础上给予甲茅软肝汤加减治疗。治疗3个月后观察肝功能水平,评价临床疗效。 结果 治疗组肝功能改善情况明显优于对照组,差异有统计学意义(P<0.05);治疗组总有效率为82.98%,明显优于对照组的63.04%,差异有统计学意义(P<0.05)。 结论 甲茅软肝汤加减联合西药能显著改善肝硬化腹水患者的临床症状,明显改善肝功能指标,纠正并发症,疗效确切。

[关键词] 肝硬化腹水;甲茅软肝汤;中西医结合治疗;效果观察

[中图分类号] R575.2 [文献标识码] A [文章编号] 1674-4721(2014)09(c)-0129-03

Effect observation of modified Jiamao Ruangan decoction combined with western medicine in the treatment of ascites due to cirrhosis

YE Xin-zhou

Department of Hepatopathy,Traditional Chinese Medicine Hospital of Xiaochang County in Hubei Province,Xiaochang 432900,China

[Abstract] Objective To explore the clinical effect of modified Jiamao Ruangan decoction combined with western medicine in the treatment of ascites due to cirrhosis. Methods One hundred and eighty-six patients with ascites due to cirrhosis were randomly divided into treatment group (94 cases) and control group (92 cases).The control group were given regular treatment including liver protection,anti-virus,anti-infection,albumin infusion at regular intervals,supporting,dieresis,and drainage from abdominal cavity,the treatment group was given Jiamao Ruangan decoction on the basis of control group.After 3 months treatment,liver function indexes were observed,and clinical effect was evaluated. Results The improvement of liver function indexes in treatment group was better than that in control group,with statistical difference(P<0.05).The total clinical effective rate of treatment was 82.98%,significantly higher than that of control group(63.04%),with statistical difference(P<0.05). Conclusion Modified Jiamao Ruangan decoction combining with western medicine can remarkably improve the clinical manifestations in patients with ascites due to cirrhosis and liver function indexes,and correct the complications with a definite effect.

[Key words] Ascites due to cirrhosis;Jiamao Ruangan decoction;Combined treatment of traditional chinese and western medicine;Effect observation

肝硬化腹水是由于内分泌紊乱或血浆白蛋白减少导致血浆胶体渗透压降低而引起。大量腹水时腹内压增高,可引起呼吸困难甚至发绀,亦可诱发反流性食管炎而出现灼心及胸骨后不适或疼痛等症状,病变逐渐进展,可出现肝功能衰竭、门静脉高压和多种并发症,死亡率高[1]。临床上多数肝硬化腹水患者都是由慢性乙型肝炎逐步发展而来,乙型肝炎病毒(hepatitis B virus,HBV)感染者遍及世界各地,据估计,全球范围内每年有超过20万慢性HBV感染者死于肝硬化和肝细胞癌等终末期肝病[2]。本研究采用自拟甲茅软肝汤加减联合西药治疗肝硬化腹水,探讨其效果。

1 资料与方法

1.1 一般资料

选取本院2010年10月~2013年10月收治的186例肝硬化腹水患者作为研究对象,临床诊断参照中华医学会传染病与寄生虫病分会修订的《病毒性肝炎防治方案》[3]中有关失代偿性肝硬化诊断标准,且全部病例均经B超检查腹腔内有液性暗区,PV>1.0 cm,大量腹水持续3个月以上,肝功能异常。……

登录APP查看全文